Trial intelligence / Profile preview

Tramadol plus adrenaline versus lidocaine plus adrenaline for local anaesthesia in facial wound repair

PACTR202610579761488Phase 3Not yet recruiting

Sponsor
Faculty of Medicine and Biomedical Sciences, University of Yaoundé I
Start
Nov 2026
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of tramadol, lidocaine and epinephrine in Facial wound (2 arms), sponsored by Faculty of Medicine and Biomedical Sciences, University of Yaoundé I. Primary endpoint: Duration of analgesia. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

tramadollidocaineepinephrine
03

Conditions

Facial wound

Beyond the preview

Go deeper on PACTR202610579761488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202610579761488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call